TGFβ Regulation of Perilacunar/Canalicular Remodeling Is Sexually Dimorphic
Open Access
- 13 April 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 35 (8) , 1549-1561
Abstract
Bone fragility is the product of defects in bone mass and bone quality, both of which show sex-specific differences. Despite this, the cellular and molecular mechanisms underpinning the sexually dimorphic control of bone quality remain unclear, limiting our ability to effectively prevent fractures, especially in postmenopausal osteoporosis. Recently, using male mice, we found that systemic or osteocyte-intrinsic inhibition of TGFβ signaling, achieved using the 9.6-kb DMP1 promoter-driven Cre recombinase (TβRIIocy−/− mice), suppresses osteocyte perilacunar/canalicular remodeling (PLR) and compromises bone quality. Because systemic TGFβ inhibition more robustly increases bone mass in female than male mice, we postulated that sex-specific differences in bone quality could likewise result, in part, from dimorphic regulation of PLR by TGFβ. Moreover, because lactation induces PLR, we examined the effect of TGFβ inhibition on the female skeleton during lactation. In contrast to males, female mice that possess an osteocyte-intrinsic defect in TGFβ signaling were protected from TGFβ-dependent defects in PLR and bone quality. The expression of requisite PLR enzymes, the lacunocanalicular network (LCN), and the flexural strength of female TβRIIocy−/− bone was intact. With lactation, however, bone loss and induction in PLR and osteocytic parathyroid hormone type I receptor (PTHR1) expression, were suppressed in TβRIIocy−/− bone, relative to the control littermates. Indeed, differential control of PTHR1 expression, by TGFβ and other factors, may contribute to dimorphism in PLR regulation in male and female TβRIIocy−/− mice. These findings provide key insights into the sex-based differences in osteocyte PLR that underlie bone quality and highlight TGFβ signaling as a crucial regulator of lactation-induced PLR. © 2020 American Society for Bone and Mineral Research.Keywords
All Related Versions
Funding Information
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR066262-01, AR067439)
- National Institute of Dental and Craniofacial Research (DE019284)
- National Science Foundation (1636331)
- U.S. Department of War (OR130191)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR066262‐01, AR067439)
- National Institute of Dental and Craniofacial Research (DE019284)
- National Science Foundation (1636331)
- U.S. Department of War (OR130191)
This publication has 69 references indexed in Scilit:
- Gender specific age-related changes in bone density, muscle strength and functional performance in the elderly: a-10 year prospective population-based studyBMC Geriatrics, 2013
- Matrix metalloproteinase–13 is required for osteocytic perilacunar remodeling and maintains bone fracture resistanceJournal of Bone and Mineral Research, 2012
- Determinants of undercarboxylated and carboxylated osteocalcin concentrations in type 1 diabetesOsteoporosis International, 2011
- Evidence for pleiotropic factors in genetics of the musculoskeletal systemBone, 2010
- Increased osteocyte death and mineralization inside bone after parathyroidectomy in patients with secondary hyperparathyroidismJournal of Bone and Mineral Research, 2010
- Osteocyte Remodeling of the Perilacunar and Pericanalicular MatrixInternational Journal of Oral Science, 2009
- Pharmacologic Inhibition of the TGF-β Type I Receptor Kinase Has Anabolic and Anti-Catabolic Effects on BonePLOS ONE, 2009
- A Population-Based Assessment of Rates of Bone Loss at Multiple Skeletal Sites: Evidence for Substantial Trabecular Bone Loss in Young Adult Women and MenJournal of Bone and Mineral Research, 2008
- Estrogen‐TGFβ cross‐talk in bone and other cell types: Role of TIEG, Runx2, and other transcription factorsJournal of Cellular Biochemistry, 2007
- Hip fractures in the elderly: A world-wide projectionOsteoporosis International, 1992